Viewing Study NCT01016366

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:41 PM
Ignite Modification Date: 2026-01-25 @ 1:07 AM
Study NCT ID: NCT01016366
Status: COMPLETED
Last Update Posted: 2016-11-08
First Post: 2009-11-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety Study of Carbamylated Erythropoietin to Treat Patients With the Neurodegenerative Disorder Friedreich's Ataxia
Sponsor: H. Lundbeck A/S
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Friedreich's Ataxia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neurodegenerative View
None Friedreich's Ataxia View
None FRDA View
None Erythropoietin View
None Carbamylated View
None Neuroprotection View
None Frataxin View